Document Classification

Section Type: RESULTS

Text: Though not significant, compared with the atenolol-based regimen, fewer individuals on the amlodipine-based regimen had a primary endpoint (429 vs 474 ; unadjusted HR 0. 90, 95 % CI 0. 79-1. 02, p = 0. 1052), fatal and non-fatal stroke (327 vs 422 ; 0. 77, 0. 66-0. 89, p = 0. 0003), total cardiovascular events and procedures (1362 vs 1602 ; 0. 84, 0. 78-0. 90, p < 0. 0001), and all-cause mortality (738 vs 820 ; 0. 89, 0. 81-0. 99, p = 0. 025).